PE108098A1 - ENV-GLUCOPROTEIN VACCINE FOR PROTECTION AGAINST VLCTH-I AND VLCTH-II INFECTION - Google Patents

ENV-GLUCOPROTEIN VACCINE FOR PROTECTION AGAINST VLCTH-I AND VLCTH-II INFECTION

Info

Publication number
PE108098A1
PE108098A1 PE00065397A PE00065397A PE108098A1 PE 108098 A1 PE108098 A1 PE 108098A1 PE 00065397 A PE00065397 A PE 00065397A PE 00065397 A PE00065397 A PE 00065397A PE 108098 A1 PE108098 A1 PE 108098A1
Authority
PE
Peru
Prior art keywords
vlcth
sequence
env
infection
cells
Prior art date
Application number
PE00065397A
Other languages
Spanish (es)
Inventor
William W Hall
Hidehiro Takahashi
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of PE108098A1 publication Critical patent/PE108098A1/en

Links

Abstract

SE REFIEREN A LOS POLIPEPTIDOS DE LA PROTEINA DE CUBIERTA env DEL VIRUS LINFOTROPICO DE CELULAS T HUMANAS (VCLTH-I Y VCLTHII), QUE COMPRENDE LA SECUENCIA DE AMINOACIDO CORRESPONDIENTE A LA SUBUNIDAD pg63 TRUNCADA, EN DONDE LA SECUENCIA GUIA DEL TERMINAL AMINO SE ENCUENTRA BORRADA, DE TAL MANERA QUE, CUANDO SE EXPRESA POR UNA CELULA HUESPED MANIPULADA GENETICAMENTE, NO ES ANCLADO EN LA MEMBRANA DE LA CELULA HUESPED; EN DONDE DICHAS CELULAS HUESPEDES SON CELULAS DE INSECTO BACULOVIRUS o CELULAS T. ESTAS PROTEINAS ANTIGENICAS TIENEN UTILIDAD EN LOS INMUNOENSAYOS DE DIAGNOSTICO, LA INMUNOTERAPIA PASIVA Y LA GENERACION DE ANTICUERPOS ANTIIDIOTIPICOSTHEY REFER TO THE POLYPEPTIDES OF THE ENVELOPE COVER PROTEIN OF THE T-HUMAN LYMPHOTROPIC VIRUS (VCLTH-I AND VCLTHII), WHICH INCLUDES THE SEQUENCE OF AMINO ACID CORRESPONDING TO THE SEQUINARY SEQUENCE OF THE SEQUENCE OF THE GUARANTEE SEQUENCE. , IN SUCH A WAY THAT, WHEN IT IS EXPRESSED BY A GENETICALLY MANIPULATED GUEST CELL, IT IS NOT ANCHORED IN THE MEMBRANE OF THE GUEST CELL; WHERE SUCH GUEST CELLS ARE BACULOVIRUS INSECT CELLS OR T-CELLS. THESE ANTIGENIC PROTEINS HAVE USEFULNESS IN DIAGNOSTIC IMMUNOASSAYS, AND THE GENERATION OF ANTIBODY ANTIBODIES

PE00065397A 1996-07-22 1997-07-22 ENV-GLUCOPROTEIN VACCINE FOR PROTECTION AGAINST VLCTH-I AND VLCTH-II INFECTION PE108098A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68105496A 1996-07-22 1996-07-22

Publications (1)

Publication Number Publication Date
PE108098A1 true PE108098A1 (en) 1999-01-26

Family

ID=24733624

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00065397A PE108098A1 (en) 1996-07-22 1997-07-22 ENV-GLUCOPROTEIN VACCINE FOR PROTECTION AGAINST VLCTH-I AND VLCTH-II INFECTION

Country Status (5)

Country Link
AR (1) AR003102A1 (en)
AU (1) AU3807397A (en)
BR (1) BR9711809A (en)
CO (1) CO4750675A1 (en)
PE (1) PE108098A1 (en)

Also Published As

Publication number Publication date
AU3807397A (en) 1998-02-10
BR9711809A (en) 2001-11-06
CO4750675A1 (en) 1999-03-31
AR003102A1 (en) 1998-07-08

Similar Documents

Publication Publication Date Title
DE3750339T2 (en) HTLV-III enveloping peptides.
EA199700272A1 (en) VACCINES CONTAINING SAPONIN AND STERIN
NO863803L (en) Vaccines and Immunoassays for Acquired Immunodeficiency Syndrome (AIDS).
DE3587139D1 (en) TISSUE IMPLANT.
DE69831594D1 (en) INTACT OR DESTROYED INSECT CELLS AS ANTIGENADJUVANT
DK1278534T3 (en) Methods and compositions for attenuating the multiplication of HIV-1
DE68928834T2 (en) MONOCLONAL ANTIBODIES AGAINST CAT T-LYMPHOTROPES LENTIVIRUS
KR900700507A (en) Synthetic peptide antigen for detecting HTLV-1 infection
ES2013328A6 (en) Synthetic peptide antigens for the detection of HIV-1 infection.
FR2669338B1 (en)
KR910019641A (en) Serum Reactive Epitopes on Proteins of Human Papilloma Virus (HPV) 18
BR0017136A (en) Hla-binding peptides and their uses.
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
AR004567A1 (en) METHODS TO DETECT THE T. CRUZI INFECTION, IN A BIOLOGICAL SAMPLE, A RECOMBINANT VECTOR OF EXPRESSION, A MODIFIED MICROORGANISM, A DIAGNOSTIC KIT, A PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF A MEDICINE PRODUCTION OF ANTIBODIES THAT LINK TO T. CRUZI.
PE108098A1 (en) ENV-GLUCOPROTEIN VACCINE FOR PROTECTION AGAINST VLCTH-I AND VLCTH-II INFECTION
DE69928064D1 (en) MIMOTOPES OF THE HYPERVARIABLE REGION OF THE E2 GLYCOPROTEIN OF HCV AND ITS USES
DE60130634D1 (en) IDENTIFICATION OF ANTIGENIC PEPTIDES BY CYTOTOXIC T-LYMPHOCYTIVES ACTIVATED BY DENDRITIC CELL HYBRIDS
ES2113860T3 (en) PEPTIDES WITH PROTECTED THYOL CYSTEINE GROUPS, USEFUL IN IMMUNOLOGICAL TESTS.
ES2194900T3 (en) PEPTIDES OF EQUINE ARTERITIS VIRUS, ANTIBODIES AND ITS USE IN A DIAGNOSTIC TEST.
DK173905B1 (en) HIV-related polypeptides, diagnostic systems and methods of analysis
DE69635856D1 (en) ANTIGENIC HA-2 PEPTIDE
BAUM et al. Inappropriate expression of mitochondrial antigens in breast cancer
EP1013766A3 (en) Peptides for the detection of HIV-1-Group O
ATE383371T1 (en) PTPRK IMMUNOGENE PEPTIDE
SU1533329A1 (en) HYBRID ANIMAL CULTIVATED ANIMAL CELLS STRAIN MUS MUSCULUS, USED TO OBTAIN MONOCLONAL ANTIBODIES TO THE PROTECTIVE VIRUSES OF VIRUS ENCEPHALITE VIRUSES

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed